A prospective open labelled, single arm, non - randomized, single centric, phase II clinical trial to determine the effectiveness of ayavathi chooranam in the management of deepana silethma noi (dyslipidemia)

This study is a prospective open labelled, single arm, non-randomized, single centric, phase II clinical trial to determine the effectiveness of AYAVATHI CHOORANAM in the management of DEEPANA SILETHMA NOI(DYSLIPIDEMIA). After purifictaion of trial drugs ayavathi chooranam will be prepared and administered for 48 days for 40 patients.The primary outcome will be to determine the clinical efficacy of ayavathi chooranam (internal) in the management of dyslipidemia and to evaluate the changes in LDL anf TG from baseline to 48th day. The secondary outcome will be to collect various aspects of deepana silethma noi in siddha literatures, to evaluate pharmacological analysis of ayavathi chooranam, to study about the prevalence of deepana silethma noi in relation between diet and lifestyle, to evaluate siddha parameters (including envagai thervu, neerkuri, neikuri) changes in deepana silethma noi, to evaluate the change in serum TC,LDL at 48th day, to document the biostatistical analysis, to assess the quality of life of deepana silethma noi patients.